title: Drug-induced hypersensitivity syndrome induced by clindamycin.
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Nakamura
authors.forename: Kenya
authors.initials: K
authors.lastname: Watamatsu
authors.forename: Masahiko
authors.initials: M
authors.lastname: Muto
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001219:Aspartate Aminotransferases / Q000097:blood; D001623:Betamethasone / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000032:analysis; D002981:Clindamycin / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology*; D005076:Exanthema / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D005334:Fever / Q000139:chemically induced* / Q000188:drug therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007964:Leukocytosis / Q000139:chemically induced* / Q000188:drug therapy; D013577:Syndrome
chemical_list: D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D002981:Clindamycin; D002097:C-Reactive Protein; D001623:Betamethasone; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase